Vistin Pharma ASA (VISTN.OL)
- Previous Close
25.70 - Open
25.00 - Bid 24.80 x --
- Ask 25.00 x --
- Day's Range
24.50 - 25.50 - 52 Week Range
20.70 - 28.80 - Volume
178,855 - Avg. Volume
51,918 - Market Cap (intraday)
1.109B - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
14.37 - EPS (TTM)
1.74 - Earnings Date Apr 25, 2025
- Forward Dividend & Yield 1.25 (4.86%)
- Ex-Dividend Date Jun 4, 2025
- 1y Target Est
--
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
www.vistin.com71
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: VISTN.OL
View More
Performance Overview: VISTN.OL
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is OBX Total Return Index (OBX.OL) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VISTN.OL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VISTN.OL
View MoreValuation Measures
Market Cap
1.14B
Enterprise Value
1.13B
Trailing P/E
14.77
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.59
Price/Book (mrq)
3.44
Enterprise Value/Revenue
2.56
Enterprise Value/EBITDA
9.63
Financial Highlights
Profitability and Income Statement
Profit Margin
17.43%
Return on Assets (ttm)
14.61%
Return on Equity (ttm)
24.44%
Revenue (ttm)
440.66M
Net Income Avi to Common (ttm)
76.79M
Diluted EPS (ttm)
1.74
Balance Sheet and Cash Flow
Total Cash (mrq)
12.67M
Total Debt/Equity (mrq)
0.60%
Levered Free Cash Flow (ttm)
37.99M